期刊文献+

谈糖尿病肾病从瘀论治 被引量:11

On Treatment of Diabetic Nephropathy from Stasis
下载PDF
导出
摘要 糖尿病肾病是临床上常见的糖尿病微血管并发症之一。目前普遍认为血瘀与糖尿病肾病的发生发展关系密切,瘀血作为糖尿病肾病的病理产物和致病因素而贯穿于本病的始终,活血化瘀通络治疗糖尿病肾病已取得了良好的临床疗效,积累了丰富的临床经验。从瘀论治疗糖尿病肾病可在一定程度上改善患者的临床症状,保护肾功能,延缓肾功能恶化的进展,可对糖尿病肾病的诊疗及预后产生积极的影响。 Diabetic nephropathy is one of the common diabetic microvascular complications.At present,it is generally believed that blood stasis is closely related to the occurrence and development of diabetic nephropathy.Blood stasis,as a pathological product and pathogenic factor of diabetic nephropathy,runs through the whole course of the disease.The treatment of diabetic nephropathy by promoting blood circulation,expelling blood stasis,dredging collateral has achieved good clinical results and has accumulated a wealth of clinical experience.So,treating diabetic nephropathy from stasis can improve the clinical symptoms,protect the renal function,delay the progress of deterioration of renal function,and have a positive effect on the diagnosis,treatment and prognosis of diabetic nephropathy.
作者 张庆飞 王祥生 Zhang Qingfei;Wang Xiangsheng(Shandong University of Chinese Medicine,Jinan China,250013;Jining TCM Hospital of Shandong Province,Jining China,272099)
出处 《现代中医药》 CAS 2018年第6期90-92,共3页 Modern Chinese Medicine
关键词 糖尿病肾病 瘀血症 活血化瘀 扶正 diabetic nephropathy blood stasis promoting blood circulation and expelling blood stasis strengthening vital qi
  • 相关文献

参考文献7

二级参考文献17

  • 1翁建平.糖尿病肾病的诊断与治疗[J].临床内科杂志,2005,22(3):150-153. 被引量:79
  • 2杨霓芝,刘旭生.糖尿病肾病诊断、辨证分型及疗效评定标准(试行方案)[J].上海中医药杂志,2007,41(7):7-8. 被引量:1173
  • 3中华人民共和国卫生部.中药新药治疗消渴病(糖尿病)的临床研究指导原则[S].,1987.215~218. 被引量:5
  • 4[2]Ishii H, Majerus PW. Thrombomodulin is present in human plasma and urine. J. Clin. Invest. 1985, 76(6):2178. 被引量:1
  • 5[4]Davies PF, Tripathi SC. Mechanical stress mechanism and the cell.An endothelial paradigm. Circ Res, 1993,72(2):239. 被引量:1
  • 6[6]Lehmann R, Schleicher ED. Molecular mechanism of diabetic nephropathy. Clin Chim Acta, 2000,297(1-2):135. 被引量:1
  • 7[7]Ceriello A, Quatraro A, Giugliano D. New insights on nonenzymatic glycosylation may lead to therapeutic approaches for the prevention of diabetic complications. Diabet Med, 1992,9 (3): 297. 被引量:1
  • 8[8]Maiello M, Boeri D, Podesta F, et al. Increased expression of tissue plasminogen activator and its inhibitor and reduced fibrinolytic potential of human endothelial cells cultured in elevated glucose.Diabetes, 1992,41(8) :1009. 被引量:1
  • 9[9]Shimomura I, Funahashi T, Takahashi M, et al. Enhancedexpression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nature Med, 1996,2(7):800. 被引量:1
  • 10Mogensen CE.Early diabetic renal involvement and nephathy[A].In:Alberthy KGMM,Krall LP.The Diabtes Annual[M].Vol3,Qmsterdam,Elsevier Sceince Publishers,1987.306. 被引量:1

共引文献266

同被引文献182

引证文献11

二级引证文献61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部